Ekso Bionics (NASDAQ:EKSO) Issues Earnings Results, Misses Expectations By $0.04 EPS

Ekso Bionics (NASDAQ:EKSO) issued its quarterly earnings data on Monday. The company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.04), Yahoo Finance reports. The company had revenue of $3.76 million for the quarter, compared to the consensus estimate of $4.99 million. Ekso Bionics had a negative net margin of 79.48% and a negative return on equity of 93.53%. During the same period in the previous year, the business earned ($0.33) EPS.

Ekso Bionics Trading Down 3.9 %

Ekso Bionics stock opened at $1.24 on Wednesday. The company has a quick ratio of 1.87, a current ratio of 2.49 and a debt-to-equity ratio of 0.38. Ekso Bionics has a 52 week low of $0.62 and a 52 week high of $3.13. The company has a market capitalization of $22.44 million, a price-to-earnings ratio of -1.28 and a beta of 1.61. The stock has a 50-day moving average price of $1.47 and a 200 day moving average price of $1.63.

Analyst Upgrades and Downgrades

EKSO has been the subject of several recent analyst reports. StockNews.com raised Ekso Bionics from a “sell” rating to a “hold” rating in a report on Thursday, April 4th. HC Wainwright raised their price target on Ekso Bionics from $9.25 to $10.00 and gave the stock a “buy” rating in a report on Tuesday.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.